Loxo Oncology Inc. (LOXO) Stock Price, Forecast & Analysis
USA - NASDAQ:LOXO -
LOXO Key Statistics, Chart & Performance
The current stock price of LOXO is 234.66 null. In the past month the price increased by 0.6%. In the past year, price increased by 123.91%.
LOXO Latest News, Press Relases and Analysis
About LOXO
Company Profile
Loxo Oncology, Inc. is a biopharmaceutical company. It develops targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Loxo Oncology, Inc. is headquartered in Stamford, Connecticut.
Company Info
Loxo Oncology Inc.
281 TRESSER BOULEVARD 9TH FLOOR
STAMFORD CT 06901
CEO: Joshua H. Bilenker
Phone: 203-653-3880
Loxo Oncology Inc. / LOXO FAQ
What does LOXO do?
Loxo Oncology, Inc. is a biopharmaceutical company. It develops targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Loxo Oncology, Inc. is headquartered in Stamford, Connecticut.
What is the stock price of Loxo Oncology Inc. today?
The current stock price of LOXO is 234.66 null. The price decreased by -0.03% in the last trading session.
Does Loxo Oncology Inc. pay dividends?
LOXO does not pay a dividend.
What is the ChartMill rating of Loxo Oncology Inc. stock?
LOXO has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Would investing in Loxo Oncology Inc. be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LOXO.
What is the market capitalization of LOXO stock?
Loxo Oncology Inc. (LOXO) has a market capitalization of 7.18B null. This makes LOXO a Mid Cap stock.
LOXO Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to LOXO. When comparing the yearly performance of all stocks, LOXO is one of the better performing stocks in the market, outperforming 98.8% of all stocks.
LOXO Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to LOXO. Both the profitability and the financial health of LOXO get a neutral evaluation. Nothing too spectacular is happening here.
LOXO Financial Highlights
Over the last trailing twelve months LOXO reported a non-GAAP Earnings per Share(EPS) of -2.09. The EPS increased by 53.56% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -50.99% | ||
| ROA | -9.55% | ||
| ROE | -16.61% | ||
| Debt/Equity | 0 |